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Does severe venous insufficiency have a different
etiology in the morbidly obese? Is it venous?
Frank Padberg, Jr, MD, Joaquim J. Cerveira, MD, Brajesh K. Lal, MD, Peter J. Pappas, MD,
Shubha Varma, MD, and Robert W. Hobson II, MD, Newark, East Orange, and Lyons, NJ
Objective: Chronic venous insufficiency (CVI) is the most common cause of leg ulcers. Patients with morbid obesity are
remarkable for particularly recalcitrant ulcers. Because obesity is not specifically incorporated in CEAP or other venous
scoring systems, we sought to characterize this group of patients more completely.
Methods: Patients with severe CVI (CEAP clinical class, 4, 5, and 6), and class III obesity (body mass index [BMI], >40)
were reviewed. Findings from clinical and duplex ultrasound scan (DU) examinations were compared with the CEAP
classification, its adjunctive venous clinical severity score, and sensory thresholds.
Results: A review of clinic records identified 20 ambulatory patients with a mean age of 62 years, a mean BMI of 52, and
a mean weight of 164 kg (361 lbs); all but one had bilateral symptoms. No evidence of venous insufficiency was detected
with DU in 24 of the 39 limbs. Although some valvular incompetence was detected with DU in 15 of 39 limbs, these
abnormalities were widely dispersed between 28 sites; eight limbs had findings at only one site. Ulceration (mean area, 29
cm2) was present in 25 limbs and necessitated 7 months for healing; 13 (52%) recurred at least once during a mean
observation period of 36 months. The mean sensory threshold of 5.21 exceeded current risk thresholds used in diabetic
screening programs. The distribution of CEAP clinical class was C4 (n  14), C5 (n  14), and C6 (n  11). Increasing
CEAP class correlated with an increased mean BMI of 47, 52, and 56, respectively (P < .01). CEAP also correlated with
a rising mean venous clinical severity score of 10, 11, and 15, respectively (P < .05).
Conclusion: Patients with class III obesity had severe limb symptoms, typical of CVI, but approximately two thirds of the
limbs had no anatomic evidence of venous disease. The association of increasing limb symptoms with increasing obesity
suggested that the obesity itself contributes to the morbidity. (J Vasc Surg 2003;37:79-85.)
Because chronic venous insufficiency (CVI) is consid-
ered the most common cause of leg ulcers, our clinical
examination was supplemented with the noninvasive exam-
ination to determine cause, anatomic location, and patho-
physiology (CEAP) of the disorder. Reported surveys of
individuals with severe CVI have generally described a
postthrombotic cause in 38% to 44% of limbs with these
clinical findings.1,2 In similar populations, superficial valvu-
lar reflux was reported in 56% to 88% and deep valvular
reflux in 48% to 72% of limbs.2-4 Thus, when screening our
clinic population for a clinical protocol investigating the
role of physical therapy for CVI, we were surprised and
disappointed to find that many obese candidates with the
typical clinical findings of severe venous insufficiency had
little or no anatomic evidence of venous reflux or obstruc-
tion.
Skin changes (diffuse lower leg pigmentation, lipoder-
matosclerosis, healed ulceration, and active ulceration)
were the distinguishing characteristics of CEAP clinical
classifications 4, 5, and 6 and indicated greater severity of
CVI. The limbs of obese individuals were remarkable for
particularly recalcitrant ulcers, prolonged healing, and fre-
quent recurrence of leg ulceration. Although commonly
associated with venous insufficiency, obesity was not incor-
porated in the CEAP classification system.5
To characterize this group of limbs more completely,
we evaluated morbidly obese individuals with clinical, du-
plex ultrasound scan (DU), and sensory examinations. The
limbs then were classified with the CEAP system and its
adjunctive venous clinical severity score (VCSS).5-7
METHODS
Obese patients with limb symptoms typical of CVI
underwent evaluation in our Veterans Affairs clinics from
1998 to the present with a complete clinical and noninva-
sive examination. Individuals with CEAP clinical class 4, 5,
and 6 were included; those with class 3, edema of venous
origin without other findings, were excluded to reduce the
difficult distinction between CVI and other diseases affect-
ing fluid management. However, clinical factors influenc-
ing chronic fluid balance were assessed (ie, congestive heart
failure, hepatic failure, and renal failure). Height, weight,
and specific information regarding diabetes mellitus, coro-
nary heart disease, and sleep apnea were recorded as factors
known to increase the risk of mortality and morbidity
related to obesity; limbs with lower extremity arterial oc-
clusive disease were excluded if the ankle brachial index was
less than 0.75. Age was also compared because the fre-
quency of ulceration increases with age.
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Obesity was determined on the basis of the body mass
index (BMI), which was calculated as the weight in kg
divided by the height in cm2. Obesity is defined as BMI of
more than 30; class II morbid obesity is defined as BMI 35
to 40, and class III as BMI 40 or more.8,9 The risks of
mortality and complications are increased for individuals
with a higher classification, which is used to guide thera-
peutic recommendations and to individualize manage-
ment. Inclusion in this report was restricted to subjects with
BMI of 40 or more (class III).
Duplex ultrasound scan examinations were conducted
on a Siemens Sonoline Elegra or a Siemens Quantum 2000
(Iselin, NJ), with 2.5-multihertz to 7.5-multihertz probes.
An imaging survey evaluated both lower extremities for
patency, compressibility, wall thickness, scarring, and
thrombosis of any age. Spectral Doppler survey evaluated
each vein for spontaneous phasic flow and response to
augmentation. Sites examined included the common fem-
oral, superficial femoral (proximal and distal), popliteal
(proximal and distal), posterior tibial, peroneal, gastrocne-
mius, greater saphenous (above-knee and below-knee),
lesser saphenous, and perforating veins of the thigh and
lower leg. Limbs were evaluated in the standing position
and reflux noted when retrograde flow persisted for greater
than 0.5 seconds after distal compression and release.10,11
New methods of patient assessment incorporating the
adjunctive VCSS and pressure aesthesiometry were intro-
duced in 1999 to 2000.6,7 Because this retrospective review
includes patients who underwent evaluation from 1998 to
the present, these scores were only applied to 27 of the 39
limbs. The VCSS has 10 items with severity rated from 0 to
3 by the examiner; it was reported as a numeric score, which
ranged from 0 to 30 and increased linearly with the clinical
classification. A mean score of 14.9  2.88 was reported
with C6 CVI.12 Three items specific to ulcer severity were
number, duration, and size; recurrence, which was not
specifically scored, was also noted. The last VCSS item
scored compliance with stocking use as 3 points and non-
compliant individuals with 0 points; to facilitate compli-
ance, gradient compression hosiery were provided at no
cost.
Pressure aesthesiometry determined the sensory
threshold for lower leg skin and has been related to the
susceptibility to local injury. Scores are expressed as a
logarithmic value that represents the pressure applied by a
graded series of filaments. An increased risk of ulceration
and limb loss has been documented with values of more
than 5.07 in patients with diabetes mellitus.13 In previous
work, we characterized the sensory threshold in the supra-
malleolar skin to be 4.65 (range, 4.08 to 6.65) in limbs
with C5 CVI.7 Thus, higher sensory thresholds suggest
that limbs with CVI may also be more susceptible to skin
injury (ie, ulceration). Scores were generally assigned by
one individual (FP) or by surgical resident staff under
supervision.
Age, BMI, VCSS, and sensory threshold scores were
compared between CEAP clinical classes. Patients and
limbs with objective ultrasound scan findings (DU) were
compared with those who had no findings (DU). Com-
parisons were made with Student t test, assigning signifi-
cance when the P value was less than .05. Data were
expressed as mean  standard deviation. The review was
approved by the Institutional Review Board. To simplify
presentation of the data, comparisons between the clinical
classes were analyzed on the basis of each limb. However,
patient-specific data, age, and BMI were also compared by
assigning each patient’s “worst” or most severely involved
limb on the basis of clinical class. The worst limb was
selected because it was the most likely to limit patient
behavior. Because VCSS and pressure aesthesiometry
scores are limb specific, these data were evaluated with a
comparison of limbs.
RESULTS
Twenty male patients (39 symptomatic limbs) had a
mean age of 62 years, a mean height of 178 cm (70 in), and
a mean weight of 164 kg (361 lbs). All 20 had class III
morbid obesity, with a mean BMI of 52. All but one had
bilateral symptoms consistent with apparent CVI. Diabetes
mellitus was present in 10 patients (50%), coronary artery
disease in eight, congestive failure in eight, and sleep apnea
in five. Hepatic insufficiency was minimal, and only one
individual had renal insufficiency on the basis of a creatinine
level of 2.5 (Table I).
Twenty-five limbs had healed or active ulcerations.
Mean ulcer size was 29 cm2, and a mean of 7 months was
necessary to heal. Two have never healed, with a mean
follow-up of 3 years. Recurrent ulceration has occurred in
13 limbs; in addition, during preparation of the manu-
Table I. Clinical factors (20 patients)
Mean Median Range
Age (y) 62 59 51-78
Height (cm) 178.1 180.3 167-193
Height (in) 70 71 66-76
Weight (kg) 163.8 158 114-218
Weight (lbs) 361 348 252-481
BMI 52 52 40-63
Comorbid disease
DM 10 (50%)
CAD 8 (40%)
CHF 8 (40%)
Sleep apnea 5 (25%)
Renal insufficiency 1 (5%)
Percentages given are for number of patients out of 20.
DM, Diabetes mellitus; CAD, coronary artery disease; CHF, congestive
heart failure.
Table II. Ulcer characteristics (25 of 39 limbs)
Mean area 29 cm2
Mean time to heal 7 mo (227 d)
Never healed 2 limbs
Recurrence 13 of 25 (52%)
Usual location Anterior/lateral calf
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script, one patient with C4 disease had progression to C6,
active ulceration. Location of the ulceration was often
atypical; the ulcers were located in the proximal anterior or
lateral calf of 10 limbs. These data are summarized in Table
II.
The limb distribution of CEAP clinical class is summa-
rized in Table III. The distribution was 14 C4 (36%), 14
C5 (36%), and 11 C6 (28%). Limbs without noninvasive
evidence of anatomic venous insufficiency had a similar
CEAP distribution 10 C4 (42%), six C5 (25%), and eight
C6 (33%).
Ultrasound scan examinations of the lower extremity
veins were normal in 24 of the 39 limbs (62%); neither
reflux nor scarred vein walls nor obstruction was observed
with DU in either the deep or superficial system of either
limb in these patients. Thus, with only physical findings to
evaluate, CEAP characterization of etiology, anatomy, and
pathophysiology could not be assigned further in these 24
limbs.
Ultrasound scan examinations identified 28 sites of
venous valvular incompetence in the remaining 15 limbs.
Two subjects accounted for 14 of the 28 abnormal sites
(50%). Bilateral saphenous and popliteal reflux was ob-
served in one individual who had no DU evidence of old
thrombus, despite a prior history of bilateral deep venous
thrombosis. The second individual, whose ulcer recurred
after a 20-lb weight gain, also had bilateral superficial
incompetence. Both declined operative intervention. The
remaining 11 limbs had venous incompetence in a total of
14 sites with DU. These were remarkable for a paucity of
findings; eight limbs had only a single site of incompetence.
The distribution was typical with a predominance of super-
ficial reflux mixed with the deep and perforating veins.
These findings are detailed in Table III.
BMI, VCSS, and neurosensory scores were compared
between clinical classes C4, C5, and C6 and with the
aggregate data of C5 with C6 (C56). These data are
summarized in Table IV. VCSS scores were obtained on 30
of the 39 limbs, with a mean of 12 5. An increase in BMI
and VCSS was observed with increases in CEAP classifica-
tion. Differences were observed in the comparisons be-
tween C4 and C6 and between C4 and C56 for both BMI
and VCSS (Table IV; Fig). Compliance with elastic com-
pression garments was poor at best; only two individuals
claimed successful routine use. Pressure aesthesiometry was
obtained in 27 of the 39 limbs; the mean neurosensory
score was 5.21 0.8 (range, 4.08 to 6.45). No differences
were detected between CEAP classes in these obese pa-
tients.
In nine individuals, the two lower limbs differed with
respect to CEAP clinical class. Therefore, to accurately
present patient-specific variables (age and BMI), we also
analyzed the data according to the patients worst limb
(Table V) as opposed to analysis on the basis of each limb.
No age differences were identified between groups. Again,
as with the individual limb analysis, significant differences
between C4 and C6 and between C4 and C56 were
observed for BMI (Table V).
Age, BMI (Table V), VCSS, and neurosensory scores
(Table VI) were compared between those with no anatomic
Table III. DU: Distribution of findings in 39 limbs
CEAP
clinical
class
Duplex (): 15 limbs with 28 sites of reflux
Duplex(-):
(normal) Total
Superficial Deep
Perforating
veins
Total
sites
No. of
limbs
No. of
limbs
No. of
limbsGSV LSV CFV POP
CEAP 4 1 — — 2 2 5 4 10 14 (36%)
CEAP 5 8 3 — 3 4 18 8 6 14 (36%)
CEAP 6 2 1 1 1 — 5 3 8 11 (28%)
Total 11 4 1 6 6 28 15 (38%) 24 (62%) 39 (100%)
No limbs were identified with evidence of active or previous thrombosis; no profunda, superficial femoral vein, or tibial vein incompetence was detected.
GSV, Greater saphenous vein; LSV, Lesser saphenous vein; CFV, common femoral vein; POP, popliteal.
Table IV. Comparison of obesity (BMI), clinical severity (VCSS), and neuropathy according to CEAP clinical class
BMI VCSS Neurosensory Score
Groups compared
No. of
limbs BMI P value
No. of
limbs VCSS P value
No. of
Limbs
Neurosensory
score P value
CEAP 4 14 47  7 .075 9 10  4 NS 7 5.20  0.8 NS CEAP 4 versus 5
CEAP 5 14 52  8 NS 11 11  5 NS 10 5.06  0.7 NS CEAP 5 versus 6
CEAP 6 11 56  7 .0053 10 15  5 .018 10 5.38  0.9 NS CEAP 4 versus 6
CEAP 5  6 25 54  7 .0094 21 13  5 .05 20 5.22  0.8 NS CEAP 4 versus 5  6
All limbs 39 52  8 — 30 12  5 — 27 5.21  0.8 — —
Values expressed as mean  standard deviation.
NS, Not significant.
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findings (DU) and those with observed reflux (DU).
No differences were observed between age, BMI, or VCSS;
a difference was detected in sensory thresholds between
those with (4.84  0.6) and without (5.56  0.8) venous
abnormalities with DU (Table VI).
DISCUSSION
Severe limb symptoms, typical of CVI, increased in
severity (CEAP class and VCSS) with the magnitude of the
obesity (BMI). Approximately two thirds of these limbs
had no anatomic evidence of venous disease. In contrast,
published surveys of C4, C5, and C6 patients with similar
venous symptoms reported that approximately 50% to 88%
will have superficial incompetence and 48% to 72% will have
deep vein incompetence.1-4 Postthrombotic abnormalities
were present in 44% of a C5 population evaluated with
contrast venography and in 38% of the C4, C5, and C6
population reported by the North American Subfascial
Endoscopic Perforator Surgery registry.1,2 Both BMI and
venous severity scores increased with CEAP clinical class,
and no relationship to findings with DU was observed.
These data suggest that class III morbid obesity should be
considered a major contributing factor to severe symptom-
atology, whether it is venous in origin or not.
There are several alternative explanations for this dis-
crepancy. First, there appears to be a correlation between
the magnitude of the obesity and the severity of these
presumably venous symptoms. Massive obesity probably
produces a relative obstruction to lower extremity venous
return similar to the effects of ascites. Although many of
these individuals also had cardiac failure, this common
comorbidity of morbid obesity does not explain the find-
ings in those patients who did not have cardiac failure. The
combined effects of increased demand on cardiac output
may be additive to diminished venous return to produce
central arteriovenous dysfunction.14 In view of the excel-
lent renal and hepatic function in these subjects, these
would appear to be minimal factors. Another likely poten-
tial cause is lymphatic obstruction. Repetitive episodes of
cellulitis would be expected to lead to scarring of the
lymphatic channels. Perhaps more important, however,
lymphatic return flow may also be compromised by the
same adverse intraabdominal pressure hemodynamics as
venous return flow. Perhaps it is a combined effect of
lymphovenous hypertension.
We have also noted a strong association between recur-
rent ulceration and sensory impairment. Although local-
ized sensory impairment has been associated with diabetes
mellitus, leprosy, and now CVI, the relationship between
the sensory abnormality and obesity remains undefined.7,13
Clearly, there is considerable opportunity for additional
investigations regarding the role of sensory impairment in
this population.
Morbid obesity is now regarded as second only to
cigarette smoking as the underlying cause of death in the
United States, producing an estimated mortality rate of
280,000/y.8,15 Obesity is becoming an increasingly com-
mon problem throughout the world, affecting both adult
and pediatric populations, industrialized and developing
nations.8,9 The prevalence of class III morbid obesity dou-
bled from 1.3% to 2.9% in the decades of the 1980s and
1990s.8 Obesity, defined as a BMI of more than 30, is now
estimated to have reached a prevalence of 19.8% (or 1/5) in
the population of the United States.8 Individuals consid-
ered to be at a particularly high risk are those with comor-
bidities of coronary artery disease, type 2 diabetes, and sleep
apnea.9 The risk of development of heart failure in relation-
ship to obesity was recently characterized in men. The risk
increased by 5% for each increment of 1 in BMI.16
In addition to the apparent manifestations of CVI,
morbid symptoms attributed to severe obesity include gy-
necologic abnormalities, stress incontinence, hypertension,
esophageal reflux, cirrhosis, cholelithiasis, intertriginous
dermatitis, depression, pseudotumor cerebri, and advanced
osteoarthritis of the hip and knee.8,9,17 Limb-threatening
popliteal arterial injuries have resulted from deceivingly
innocuous mechanisms of injury.18 Severe reductions in the
Graphic comparison of CEAP clinical class for all 39 limbs, as
represented in Table IV. In addition, as noted in text and Table V,
when comparing BMI between clinical classes for worst limb, the
same differences were observed. A, BMI. B, VCSS.
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quality of life and increased symptoms of bodily pain ac-
company morbid obesity.19
Individuals with excess body mass had their ulcerations
heal more slowly and had recurrence more frequently than
that reported for other venous patients. The 7-month mean
time to healing greatly exceeded the 10-week interval re-
ported by Marston et al3 for 24-cm2 ulcerations and the 54
days by the North American Subfascial Endoscopic Perfo-
rator Surgery registry.2 If one accepts the premise that
diminished protective sensation predisposed to injury in the
gaiter area, the elevated sensory threshold of 5.21 offers
one explanation for the frequency of ulceration in the
morbidly obese population. Although many patients kept
regular attendance, most were incapable of donning regular
stockings, much less standard footwear, or a graduated com-
pression garment dispensed from our clinic. Many obese
individuals are physically incapable of reaching their feet, and
most were unable to see the foot. A key clue was the slip-in
sandal with no heel. The relative difficulty and slower deliber-
ate pace of simple bodily functions (standing, sitting, lying
down) may be additive to visual and sensory impairment in
fostering skin breakdown leading to ulceration.
The normal methods for management of CVI are
poorly used in this patient population for a variety of
different reasons. Compression therapy was probably ap-
propriate, but compliance was poor. Physical inability to
place compression garments can be achieved by enlisting
the support of a family member but is still limited by the
need for custom measurement. An adjustable velcro gar-
ment is easier to apply but also requires additional person-
nel to don effectively. With diligence and persistence, most
of these ulcers could be healed, but 50% recurred within 3
years. For comparison, the recurrence rate of venous ulcer-
ation was characterized by various reports as 29% at 5 years,
38% at 3 years, and 28% at 2 years.2,3,20 Although decreased
activity was likely associated with decreased calf pump
function, little data existed to prove this supposition. De-
spite the major risks associated with gastric bypass, the
reported results indicate that this may be one of the most
effective management tools available.
Because of the fatal and morbid complications associ-
ated with uncontrolled obesity, surgical gastric bypass has
become an increasingly common procedure.8,9 Sugarman
et al17 suggested that secondary complications in the obese
population were related to the effects of chronically ele-
vated abdominal compartment pressures. They have pre-
sented evidence, in the form of bladder pressure measure-
ments (mean, 19 cm H2O) to corroborate this theory. Of
direct relevance was the clinical reversal of venous symp-
toms (edema, ulceration) in individuals who achieved suc-
cessful weight loss after surgical gastric bypass therapy.17
Notably, their patients with venous stasis were the most
obese (mean BMI of 61) and had greater comorbidity.
Our report compares anatomic results from duplex scan
examinations to clinical findings but would be strength-
ened with the addition of hemodynamic data. We at-
tempted to obtain physiologic data with air plethysmogra-
phy but considered these examinations too variable and
unreliable to justify reporting. Although duplex scan exam-
inations of extremity venous structures were surprisingly
Table V. Comparison of severity of obesity and severity of CVI according to CEAP clinical class and DU findings ( or
) for individual patients
Worst limb
No. of
patients Age (y) P value BMI P value
Groups
compared
20 62  8 — 51  8 — —
CEAP 4 4 67  11 NS 44  3 NS C4:5
CEAP 5 7 62  7 NS 49  8 .06 C5:6
CEAP 6 9 59  8 NS 56  7 .001 C4:6
C5  C6 16 61  7 NS 53  8 .042 C4:5  6
Duplex findings
DU 9 63  8 NS 50  8 NS DU:DU
DU 11 61  8 — 52  9 NS —
Because age and BMI are patient-specific variables, patients were assigned according to their worst limb for this comparison.
Values expressed as mean  standard deviation.
NS, Not significant.
Table VI. Comparison of severity of CVI and DU findings ( or )
All limbs
No. of
limbs VCSS P value
No. of
limbs Neurosensory P value
Groups
compared
DU 13 12  5 NS 13 4.84  0.6 .014 DU:DU
DU 17 12  5 — 14 5.56  0.8 — —
All limbs 30 12  5 — 27 5.21  0.8 — —
Because VCSS and venous sensory neuropathy are limb specific, they were compared in groups defined by DU result.
Values expressed as mean  standard deviation.
NS, Not significant.
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accessible, another potential weakness of this report was the
indirect assessment of suprainguinal venous pathophysiol-
ogy. On the other hand, other investigators have also
suggested an effect of increasing BMI on severity of CVI
independent of measured venous reflux.21
Finally, one could reasonably inquire whether these
typical clinical findings of venous insufficiency satisfactorily
represent bona fide venous disease. Should these individu-
als even be classified with the CEAP system? Or should the
CEAP system be modified to include morbid obesity as an
additional etiologic factor?
The usual anatomic causes of venous insufficiency were
not sufficient to explain the severe extremity symptoms.
Localized sensory impairment may contribute to the fre-
quency of ulceration. These data suggest that class III
obesity itself contributed to the apparent venous insuffi-
ciency. In support of this consideration were the magnitude
of the venous symptoms, bilaterality, atypical location, and
the association between increasing weight and severity of
CVI.
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DISCUSSION
Dr Enrique Criado (Baltimore, Md). I have the impression
that you are really dealing with venous insufficiency. But secondary
to uncommon etiologic factors, those being, chronically sustained
venous hypertension, secondary to increased hydrostatic pressure
throughout the day. These patients have unusual habits. They very
rarely lay flat, and they sleep typically with their heads elevated and
dangling their limbs, thus rarely relieving the hydrostatic column
from their lower limbs.
And secondly, you have to consider chronic failure of the calf
muscle pump mechanism. These patients may have intact and
effective calf muscles with normal ejection fractions as measured by
air plethysmography, but they do not activate their calf muscle
pump properly throughout the day. They walk very little, they tend
to walk with their hips, barely using their calf musculature. Unfor-
tunately, we do not have any means to measure these factors during
prolonged periods of time, such as we can do for 24-hour EKG or
blood pressure monitoring.
My question to you is, whether you agree with these two
comments and whether you have any suggestions on how we could
measure these factors over time in this particular population?
Dr Frank Padberg, Jr. I agree with you. I suspect that we
will probably find an element of chronic venous hypertension. One
method with which we could access this information would be by
ambulatory venous pressures. And as you realize, that is going to
be a bit difficult in this population.
We have tried. However, I cannot give you any results as yet.
We also tried with air plethysmography. We were able to study a
few limbs, but the results were relatively unreliable, for many
reasons, one of which was that the test does require that the patient
be somewhat facile in getting out of bed and onto the floor in a
standing position while the reflux is occurring.
The chronic calf pump and the poor walking, I would agree,
we see many of these folks that still do spend a lot of time sitting in
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chairs. And I think the habit, and mobility, and a sedentary lifestyle
all contribute to this, too.
Dr Karl A. Illig (Rochester, NY). Your data are fascinating in
light of our own anecdotal experience. We have done superficial
ablation and SEPS in seven or eight morbidly obese patients and
really noticed a dramatic, almost immediate, healing of their ulcers.
We have never taken this beyond anecdote, but my sense has always
been that there is something unusual in the etiology of chronic
venous disease in the morbidly obese, and whatever it is responds
unusually well to surgery.
You report a very low incidence of surgically correctable
disease. Have you operated on any of these or similar patients, and
if so, how did they do?
Dr Padberg. That is an interesting question. I can recall at
least one patient from our series of superficial ablations who was
obese enough to qualify for this series, but his operation preceded
this time frame. However, his course was consistent with the
observations reported here—recurrence of ulceration and localized
sensory impairment, despite improved venous hemodynamics.
Dr Andre M. van Rij (Dunedin, New Zealand). We have
done a study in which we have looked at 1000 limbs and correlated
weight against some of the functions that you talked about, par-
ticularly APG. One of the interesting features is that the heavier
you are, the better your muscle pump. But the point might well be
that in the very obese, despite a good muscle pump, sedentary
activity may negate this and have something to do with worse
venous function. However I do wonder, is this really venous
disease, or is it something else?
Dr Padberg. So do we.
Dr Alan R. Koslow (Des Moines, Iowa). Apropos to some of
the studies from Oxford in the 1980s that showed that lymphatic
failure was actually the cause of a lot of venous stasis disease after
DVT, I do lymph scintigrams on my patients who are obese like
this, who have it, and I am finding marked lymphedema tartar in
these patients.
The question I have for you is, if they do lose adequate weight,
are you finding that the failure of lymphatic drainage is improving,
or is this something that we need to do a study on?
And the other thing, I agree with your comment. When I see
the patients, I tell them that there is nothing we can do to treat you
until you lose weight, and I give them a packet from the University
of Iowa Gastric Stapling Center.
Dr Padberg. I think you may be referring Mortimer’s work
that associated lymphatic disease with chronic venous insufficiency.
Like you, I suspect there probably is a lymphatic role here as well.
We have not studied this, so I cannot make any specific comments
in relationship to this group of patients. However, if there is an
obesity-related chronic venous hypertension, then there is proba-
bly also an obesity-related chronic lymphatic hypertension as well.
Like you, I believe that one of the options for these patients is
weight reduction by surgical means. One series that has shown
relief and improvement in the venous complications is referenced
in the manuscript.
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